VAERS reports by lot

Merck Pneumococcal lot T024669: VAERS reports

43 VAERS reports list lot T024669 as a Merck Pneumococcal vaccine, received between 2020-10-08 and 2022-02-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
43
Reports
5%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5237%
General / Systemic (non-local)2719%
Musculoskeletal1511%
Allergic / Anaphylactic1410%
Cardiac / Cardiovascular118%
Dermatological (non-injection-site)96%
Neurological64%
Respiratory43%
Gastrointestinal21%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida5
Georgia4
Texas3
South Carolina2
Illinois2
Nevada2
Indiana2
Michigan2
North Carolina2
Nebraska1
West Virginia1
Virginia1

Reports by month received

2020-1014
2020-119
2020-1211
2021-013
2021-021
2021-041
2021-081
2021-091
2021-111
2022-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.